XML 62 R55.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue and Segment Information - Summary of Significant Segment Expenses (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                
Total revenue $ 143,823     $ 108,761     $ 444,730 $ 319,916
Total cost of revenue 59,248     47,916     175,338 129,848
Research, development and clinical trials:                
Research, development and clinical trials 15,260     14,266     48,354 39,504
Selling, general and administrative:                
Selling, general and administrative 46,015     42,656     133,728 121,712
Other segment items [1] (1,019)     (293)     2,402 245
Net income 24,319 $ 34,907 $ 25,682 4,216 $ 12,194 $ 12,197 84,908 28,607
Cost of Net Product Revenue [Member]                
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                
Total revenue 87,677     65,861     272,011 198,918
Total cost of revenue 18,687     13,246     54,420 41,800
Cost of Service Revenue [Member]                
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                
Total revenue 56,146     42,900     172,719 120,998
Total cost of revenue 40,561     34,670     120,918 88,048
Personnel related (including stock-based compensation expense)                
Research, development and clinical trials:                
Research, development and clinical trials 6,444     5,462     18,660 16,204
Selling, general and administrative:                
Selling, general and administrative 29,234     28,188     84,212 79,567
Laboratory supplies and research materials                
Research, development and clinical trials:                
Research, development and clinical trials 2,992     3,085     13,154 9,332
Consulting and third-party services                
Research, development and clinical trials:                
Research, development and clinical trials 3,432     3,859     9,907 8,504
Clinical trials costs                
Research, development and clinical trials:                
Research, development and clinical trials 278     182     626 452
Professional and consultant fees                
Selling, general and administrative:                
Selling, general and administrative 6,395     4,086     19,649 12,636
NOP support                
Selling, general and administrative:                
Selling, general and administrative 1,173     3,558     5,511 9,101
Tradeshows and conferences                
Selling, general and administrative:                
Selling, general and administrative 1,076     353     3,051 3,218
Facility related and other                
Research, development and clinical trials:                
Research, development and clinical trials 2,114     1,678     6,007 5,012
Selling, general and administrative:                
Selling, general and administrative $ 8,137     $ 6,471     $ 21,305 $ 17,190
[1] Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.